157 related articles for article (PubMed ID: 19748824)
1. CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA.
Sendi H; Mehrab-Mohseni M; Shahraz S; Norder H; Alavian SM; Noorinayer B; Zali MR; Pumpens P; Bonkovsky HL; Magnius LO
J Clin Virol; 2009 Nov; 46(3):259-64. PubMed ID: 19748824
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.
Okamoto H; Tsuda F; Akahane Y; Sugai Y; Yoshiba M; Moriyama K; Tanaka T; Miyakawa Y; Mayumi M
J Virol; 1994 Dec; 68(12):8102-10. PubMed ID: 7966600
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
4. T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D.
Sendi H; Mehrab-Mohseni M; Zali MR; Norder H; Magnius LO
J Gen Virol; 2005 Sep; 86(Pt 9):2451-2458. PubMed ID: 16099903
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
[TBL] [Abstract][Full Text] [Related]
6. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals.
Khakoo SI; Ling R; Scott I; Dodi AI; Harrison TJ; Dusheiko GM; Madrigal JA
Gut; 2000 Jul; 47(1):137-43. PubMed ID: 10861276
[TBL] [Abstract][Full Text] [Related]
8. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
Günther S; Paulij W; Meisel H; Will H
Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocytes and CD4 epitope mutations in the pre-core/core region of hepatitis B virus in chronic hepatitis B carriers in Northeast Iran.
Zhand S; Tabarraei A; Nazari A; Moradi A
Indian J Gastroenterol; 2017 Jul; 36(4):253-257. PubMed ID: 28741237
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus: prevalence of precore/core promoter mutants in different clinical categories of Indian patients.
Gandhe SS; Chadha MS; Walimbe AM; Arankalle VA
J Viral Hepat; 2003 Sep; 10(5):367-82. PubMed ID: 12969189
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476
[TBL] [Abstract][Full Text] [Related]
12. Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe.
Tu WH; Lv Y; Zhang YM; Hou W; Wang JY; Zhang YJ; Liu HY; Zhu HX; Qin YL; Mao RC; Zhang JM
World J Gastroenterol; 2015 Jun; 21(21):6639-48. PubMed ID: 26074702
[TBL] [Abstract][Full Text] [Related]
13. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes.
Hosono S; Tai PC; Wang W; Ambrose M; Hwang DG; Yuan TT; Peng BH; Yang CS; Lee CS; Shih C
Virology; 1995 Sep; 212(1):151-62. PubMed ID: 7545853
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission.
Carman WF; Boner W; Fattovich G; Colman K; Dornan ES; Thursz M; Hadziyannis S
J Infect Dis; 1997 May; 175(5):1093-100. PubMed ID: 9129071
[TBL] [Abstract][Full Text] [Related]
15. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
[TBL] [Abstract][Full Text] [Related]
16. Occult hepatitis B virus infection with positive hepatitis B e antigen.
Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.
Penna A; Chisari FV; Bertoletti A; Missale G; Fowler P; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1991 Dec; 174(6):1565-70. PubMed ID: 1720813
[TBL] [Abstract][Full Text] [Related]
18. Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers.
Karasawa T; Shirasawa T; Okawa Y; Kuramoto A; Shimada N; Aizawa Y; Zeniya M; Toda G
J Gastroenterol; 1997 Oct; 32(5):611-22. PubMed ID: 9349986
[TBL] [Abstract][Full Text] [Related]
19. Number of mutations within CTL-defined epitopes of the hepatitis B Virus (HBV) core region is associated with HBV disease progression.
Kim D; Lyoo KS; Smith D; Hur W; Hong SW; Sung PS; Yoon SK; Mehta S
J Med Virol; 2011 Dec; 83(12):2082-7. PubMed ID: 22012714
[TBL] [Abstract][Full Text] [Related]
20. Role of core protein mutations in the development of occult HBV infection.
Chen J; Liu B; Tang X; Zheng X; Lu J; Zhang L; Wang W; Candotti D; Fu Y; Allain JP; Li C; Li L; Li T
J Hepatol; 2021 Jun; 74(6):1303-1314. PubMed ID: 33453326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
